Past studies have shown an overall correlation between CD39 expression in some lymphocytes and excellent responsiveness to rheumatoid arthritis (RA)-associated treatments or between reduced RA activity and rheumatoid factor (RF) levels (67–69). The gene discussed is ENTPD1; the disease is rheumatoid arthritis.